Crinetics Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Crinetics Pharmaceuticals's estimated annual revenue is currently $2.4M per year.
- Crinetics Pharmaceuticals received $63.5M in venture funding in March 2018.
- Crinetics Pharmaceuticals's estimated revenue per employee is $16,745
- Crinetics Pharmaceuticals's total funding is $321M.
- Crinetics Pharmaceuticals's current valuation is $1.1B. (January 2022}
- Crinetics Pharmaceuticals has 145 Employees.
- Crinetics Pharmaceuticals grew their employee count by 32% last year.
Crinetics Pharmaceuticals Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Crinetics Pharmaceuticals?
Neuropeptide Receptor Targeted Therapeutics for the Treatment of Endocrine Diseases and Cancers. We are driven by a passion for drug-hunting and tempered by a post-recession startup culture. Our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
Crinetics Pharmaceuticals News
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Forecasted to ... Defense World
Crinetics Pharmaceuticals Announces Pricing of Underwritten ... GlobeNewswire
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year ... GlobeNewswire
Photo Courtesy of Crinetics San Diego-based Crinetics Pharmaceuticals focuses on discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Radionetics Oncology, a pharmaceutical company developing radiotherapeutics, launched with $30 m ...
SAN DIEGO - October 25, 2021 - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that is has closed it ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Crinetics Pharmaceuticals Funding